Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Integrated Multi-setting Psychosocial Treatment for ADHD-Inattentive Type
This study will test the effectiveness of a new behavioral treatment, called the Child Life and Attention Skills Program, for children with attention deficit hyperactivity disorder, inattentive type.
Attention deficit hyperactivity disorder (ADHD) is a common childhood disorder in which
problems with focusing disrupt a normal life. There are two subtypes of ADHD: combined type
(ADHD-C), which includes symptoms of inattention and hyperactivity or impulsivity, and
inattentive type (ADHD-I), in which symptoms are limited to inattention. The profile of
ADHD-I, including attention deficits, comorbid disorders, social impairments, and
neurocognitive functioning, is sufficiently different from the profile of ADHD-C that
treatments effective for ADHD-C may not also be effective in treating ADHD-I. Most studies of
ADHD treatment evaluate ADHD-C, and there is very little research into treatments aimed
specifically at ADHD-I. The Child Life and Attention Skills (CLAS) Program is a behavioral
program designed specifically for ADHD-I and combines life skills training for the child,
teacher consultation, and parent training techniques adapted from ADHD-C treatments. This
study will compare the effectiveness of the CLAS Program, standard parent training, and
community referrals in treating children with ADHD-I.
Participation in this study will last 11 to 12 weeks, followed by a 5- to 7-month follow-up
period. On the basis of parent and teacher evaluations of each child's behavior, invitations
to participate in screening procedures for the study will be extended to children and their
parents. There will be two screening visits, during which the child will undergo reviews of
medical and developmental history, diagnostic interviews, intelligence testing, academic
achievement testing, and neuropsychological testing. The child and parent will be videotaped
in a series of interactions, and both will complete questionnaires about child functioning,
parent functioning, family functioning, and family relations. The child's teacher and school
principal will also be contacted to ensure that they are willing to participate in the study.
Eligible participants will then be randomly assigned to receive the CLAS Program,
parent-focused training (PFT), or community referrals. The CLAS Program will involve a
half-hour orientation and up to five half-hour weekly meetings with the child's teacher,
therapist, and parent over 11 to 12 weeks. The program will also involve ten 1.5-hour group
sessions for parents, with separate group sessions for children at the same time, and up to
five individual family sessions led by a therapist. Teachers will participate in a
school-home note system for maintaining and rewarding child behavior; parents will be taught
strategies for giving commands, using rewards and consequences, and establishing routines and
organizational schemes; and children will be taught social interaction skills, homework
skills, and organizational skills.
Participants in the PFT group will attend the ten 1.5-hour parent group sessions and up to
five individual family sessions. Participants in the community referrals group will only
receive referrals to community mental health practitioners.
All participants will undergo assessments that are similar to those in the screening visit
after completing treatment and again at a follow-up visit 5 to 7 months later. Participants
in the CLAS and PFT groups will continue monthly individual family sessions with a therapist
until undergoing the follow-up assessment.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00381407 -
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 |